Who owns CASI Pharmaceuticals, Inc., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
WEI-WU HE, Ph.D.: 58.8% · 23,985,535 shares — HUIYING MEMORIAL FOUNDATION: 3.1% · 637,644 shares — EMERGING TECHNOLOGY PARTNERS, LLC: 52.0% · 21,097,341 shares
Venrock Healthcare Capital Partners III, L.P.: 9.2% · 1,987,259 shares — VHCP Co-Investment Holdings III, LLC: 9.2% · 1,987,259 shares — Venrock Healthcare Capital Partners EG, L.P.: 9.2% · 1,987,259 shares
7 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of CASI Pharmaceuticals, Inc..
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of CASI Pharmaceuticals, Inc. they hold. Together these 17 managers report 6.09% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| VR ADVISER, LLC | $839K | 987,259 | 0.04% | 4.80% | December 31, 2025 |
| Woodline Partners LP | $113K | 133,406 | 0.00% | 0.65% | December 31, 2025 |
15 more institutional holders behind a free account
See every manager reporting CASI Pharmaceuticals, Inc., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 2 funds hold 0.16% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | $82.9K | 0.00% | 0.16% | September 30, 2023 |
| AZL DFA U.S. Small Cap Fund | $513 | 0.00% | 0.00% | March 31, 2024 |
Loading...
